/EDXC
EDXC Stock - Endexx Corporation
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+4.84%
+$0.00 (+4.84%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for EDXC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.91
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.66M | $3.91M | $2.14M | $650,515 | $1.97M |
| Gross Profit | $730,517 | $-1,148,861 | $503,009 | $-344,078 | $1.36M |
| Gross Margin | 44.1% | -29.4% | 23.5% | -52.9% | 69.2% |
| Operating Income | $-583,388 | $-5,240,200 | $-3,667,254 | $-5,371,329 | $-2,616,185 |
| Net Income | $-3,397,330 | $-6,497,937 | $-4,895,657 | $-6,808,154 | $-8,062,054 |
| Net Margin | -205.2% | -166.3% | -229.0% | -1046.6% | -409.0% |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.03 |
Company Overview
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. It provides CBD creams, oils, capsules, extracts, topicals, drinks, chocolates, and pet products, as well as hemp-derived health and beauty care products for supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited.com, as well as other online and in-store retailers. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. Endexx Corporation is headquartered in Cave Creek, Arizona.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
EDXCBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q2 2024
EPS Surprise History
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q3 22
No data
Q1 23
No data
Q1 23
No data
Q2 23
No data
Q2 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 20, 2025 | — | — | — | — |
Q1 2025 | Feb 16, 2025 | — | — | — | — |
Q2 2024 | Jun 30, 2024 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q1 2023 | Jan 17, 2023 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.05 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.04 | — | — |
Q2 2022 | May 12, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.01 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q3 2019 | Sep 30, 2019 | — | $0.00 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.02 | — | — |
Frequently Asked Questions about EDXC
What is EDXC's current stock price?
Endexx Corporation (EDXC) is currently trading at $0.00 per share. The stock has moved +4.84% today.
What is the analyst price target for EDXC?
No analyst price targets are currently available for this stock.
What sector is Endexx Corporation in?
Endexx Corporation operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is EDXC's market cap?
Endexx Corporation has a market capitalization of $0.00 billion, making it a small-cap company.
Does EDXC pay dividends?
No, Endexx Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBINP
Bionoid Pharma, Inc.
$0.03
Mkt Cap: $0.0B
BMCS
BioTech Medics, Inc.
$0.01
Mkt Cap: $0.0B
BMMJ
Body and Mind Inc.
$0.00
Mkt Cap: $0.0B
CATV
4Cable TV International, Inc.
$0.00
Mkt Cap: $0.0B
CYDX
CYduct Diagnostics, Inc.
$0.20
Mkt Cap: $0.0B
HBRM
Herborium Group, Inc.
$0.00
Mkt Cap: $0.0B
LVVEF
Yooma Wellness Inc.
$0.00
Mkt Cap: $0.0B
MJNA
Medical Marijuana, Inc.
$0.00
Mkt Cap: $0.0B
PCYN
Procyon Corporation
$0.12
Mkt Cap: $0.0B
SRUTF
Sproutly Canada Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to EDXC for comparison